Litigation
May 29, 2015
Shareholder suit against Allergan over Botox dismissed
A long-running shareholder derivative suit against the maker of Botox ended late Wednesday in dismissal by a federal judge. U.S. District Judge David O. Carter of Santa Ana dismissed the suit, ending nearly five years of litigation.
Daily Journal Staff Writer
A long-running shareholder derivative suit against the maker of Botox ended late Wednesday
in dismissal by a federal judge. U.S. District Judge David O. Carter of Santa Ana
kicked out the suit with prejudice, ending nearly five years of litigation.
The case was filed in 2010 after Botox manufacturer Allergan Inc. pleaded guilty a...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In